In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson[1], the plaintiffs successfully overcame a motion to dismiss. At the heart of the case is J&J’s legal…

IRVINE, Calif., October 16, 2024 – Knobbe Martens’ across-the-board strength in the life sciences space was again recognized by Legal Media Group (LMG), as the firm and its partners received…

IRVINE, Calif., September 11, 2024 – Knobbe Martens is pleased to share that ten of the firm’s partners have been recognized in the 2025 edition of Lawdragon’s 500 Leading Litigators…

IRVINE, Calif., September 6, 2024 – Knobbe Martens is very pleased to share that the firm took home multiple honors at the LMG Americas Life Sciences Awards yesterday in New…

In the latest installment of their Law360 column on recent noteworthy Federal Circuit decisions, partners Jeremiah Helm and Sean Murray analyze the outcome of Amarin Pharma Inc. v. Hikma Pharmaceuticals…

WASHINGTON, D.C. and SEATTLE, July 31, 2024 – A team from Knobbe Martens scored a significant victory on behalf of pharmaceutical manufacturer Lupin in Hatch-Waxman litigation against Otsuka Pharmaceutical Co….

IRVINE, Calif., July 30, 2024 – Knobbe Martens is proud to announce that the firm and several of its partners have been shortlisted across eight categories at the 2024 LMG…

Purna is an associate at the firm’s New York office. Her practice focuses on patent litigation and prosecution in the pharmaceutical, biotechnology, consumer products and medical device fields. Prior to…

IRVINE, Calif., June 21, 2024 – Knobbe Martens is proud to announce that multiple practices across the firm and two dozen partners were recognized nationally and regionally for outstanding work…

April 2024 Federal Circuit Newsletter (Japanese) April 2024 Federal Circuit Newsletter (Chinese) Obviousness Analysis Does Not Consider Unclaimed Limitations In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No….